Abstract:Abstract Transforming growth factor (TGF)-β is a pleiotropic cytokine regulating a variety of cellular processes such as cell growth, differentiation, apoptosis, migration, cell adhesion, and immune response. In the well-understood classical TGF-β signaling pathway, TGF-β activates Smad signalling via its two cell surface receptors such as TβRII and ALK5/TβRI, leading to Smad-mediated transcriptional regulation. In addition, TGF-β may also activate other signaling pathways like mitogen-activated protein kinase, PI3K, etc. The signaling of TGF-β is finely regulated at different levels. Inhibitory Smads, including Smad6 and Smad7, are key regulators of TGF-β/bone morphogenetic protein (BMP) signaling by negative feedback loops. They can form stable complexes with activated type I receptors and thereby blocking the phosphorylation of R-Smads, or recruit ubiquitin E3 ligases, such as Smurf1/2, resulting in the ubiquitination and degradation of the activated type I receptors. Besides, these inhibitory Smad proteins also inhibit TGF-β/BMP signaling in the nucleus by interacting with transcriptional repressors, such as histone deacetylases, Hoxc-8, and CtBP, or disrupting the formation of the TGF-β-induced functional Smad-DNA complexes. Smad7 is in turn regulated by different stimuli, including TGF-β, IFN-γ, TNF-α as well as ultraviolet and TPA, and mediates the crosstalk between TGF-β and other signaling pathways. Deregulation of Smad7 expression has been associated with various human diseases, such as tissue fibrosis, inflammatory disease as well as carcinogenesis. Overexpression of Smad7 has been shown to antagonize TGF-β-mediated fibrosis, carcinogenesis, and inflammation, suggesting a therapeutic potential of Smad7 to treat these diseases.

Participation of Smad2, Smad3, and Smad4 in Transforming Growth Factor β (TGF-β)-induced Activation of Smad7

Efficient TGF-beta induction of the Smad7 gene requires cooperation between AP-1, Sp1, and Smad proteins on the mouse Smad7 promoter.

Tumor suppressor bromodomain-containing protein 7 cooperates with Smads to promote transforming growth factor-β responses

Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling

Smad7 Protein Interacts with Receptor-regulated Smads (R-Smads) to Inhibit Transforming Growth Factor-β (TGF-β)/Smad Signaling

Smad7 Antagonizes Transforming Growth Factor Β Signaling in the Nucleus by Interfering with Functional Smad-DNA Complex Formation

Regulation of TGF-β Signaling by Smad7

Induction of Inhibitory Smad6 and Smad7 Mrna by Tgf-Beta Family Members

[Role of Smad Signaling in Transcription of Smad7 Gene Mediated by TGF-beta1 in Odontoblast Cell Line MDPC-23].

Human Smad3 and Smad4 Are Sequence-Specific Transcription Activators

Smad7 Enables STAT3 Activation and Promotes Pluripotency Independent of TGF-β Signaling

Physical and Functional Interaction of Murine and Xenopus Smad7 with Bone Morphogenetic Protein Receptors and Transforming Growth Factor-β Receptors

Post-translational regulation of TGF-β receptor and Smad signaling.

TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.

Signaling of Transforming Growth Factor‐β Family Members Through Smad Proteins

Regulation of TGF- signaling by Smad7

Post‐translational Regulation of TGF‐β Receptor and Smad Signaling

Phosphorylation of Ser465 and Ser467 in the C Terminus of Smad2 Mediates Interaction with Smad4 and is Required for Transforming Growth Factor-β Signaling

A 4.3 Kb Smad7 Promoter is Able to Specify Gene Expression During Mouse Development

The Differential Regulation Of Smad7 In Kidney Tubule Cells By Connective Tissue Growth Factor And Transforming Growth Factor-Beta1